Journal of Clinical Investigation reflect upon the esteem to which he was held.
Alan and colleagues were the first to demonstrate that c-Myb expression was essential in normal hematopoietic cells, and he must have taken pride as the role of Myb expanded from its beginnings in chicken retrovirusinduced leukemias to confirmation of its role in human leukemias, as well as colon, breast, and head and neck cancers. Similarly, we think he must have been pleased that targeting messenger RNA in cancers with antisense oligonucleotides has now progressed to the use of small interfering RNAs and microRNAs, keeping the dream alive that a strategy he helped pioneer may find its way into the clinic to treat cancer patients.
We remember fondly his contributions to conferences, his wit, love of scientific debate and most of all his generosity. He will be missed and long remembered from all corners of the globe and we pass on our best wishes to his family and other close friends. 
